VOYA Investment Management
ENTA icon

VOYA Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

VOYA Investment Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,126
Closed -$209K – 2746
2024
Q3 		$209K Buy
20,126
+310
+2% +$4.05K ﹤0.01% 2462
2024
Q2 		$257K Buy
19,816
+55
+0.3% +$742 ﹤0.01% 2333
2024
Q1 		$345K Sell
19,761
-2,675
-12% -$35.4K ﹤0.01% 2181
2023
Q4 		$211K Buy
22,436
+4,868
+28% +$45.4K ﹤0.01% 2562
2023
Q3 		$196K Buy
17,568
+1,639
+10% +$26.4K ﹤0.01% 2555
2023
Q2 		$341K Buy
15,929
+343
+2% +$10.1K ﹤0.01% 2294
2023
Q1 		$630K Hold
15,586
– – ﹤0.01% 1909
2022
Q4 		$725K Hold
15,586
– – ﹤0.01% 1815
2022
Q3 		$808K Sell
15,586
-51
-0.3% -$2.98K ﹤0.01% 1743
2022
Q2 		$739K Hold
15,637
– – ﹤0.01% 1593
2022
Q1 		$1.11M Buy
15,637
+538
+4% +$35K ﹤0.01% 1415
2021
Q4 		$1.13M Buy
15,099
+2,366
+19% +$186K ﹤0.01% 1470
2021
Q3 		$724K Buy
12,733
+138
+1% +$6.82K ﹤0.01% 1804
2021
Q2 		$554K Sell
12,595
-656
-5% -$32.1K ﹤0.01% 2023
2021
Q1 		$654K Buy
13,251
+342
+3% +$17.1K ﹤0.01% 1867
2020
Q4 		$543K Buy
12,909
+1,659
+15% +$73K ﹤0.01% 1865
2020
Q3 		$515K Sell
11,250
-93
-0.8% -$4.51K ﹤0.01% 1664
2020
Q2 		$570K Sell
11,343
-1,987
-15% -$103K ﹤0.01% 1586
2020
Q1 		$686K Buy
13,330
+362
+3% +$19.3K ﹤0.01% 1433
2019
Q4 		$801K Buy
12,968
+1,248
+11% +$77.4K ﹤0.01% 1594
2019
Q3 		$704K Sell
11,720
-40
-0.3% -$2.97K ﹤0.01% 1538
2019
Q2 		$992K Sell
11,760
-20
-0.2% -$1.8K ﹤0.01% 1366
2019
Q1 		$1.13M Sell
11,780
-295
-2% -$26.5K ﹤0.01% 1297
2018
Q4 		$855K Buy
12,075
+2,989
+33% +$229K ﹤0.01% 1397
2018
Q3 		$776K Buy
9,086
+2,429
+36% +$243K ﹤0.01% 1559
2018
Q2 		$772K Sell
6,657
-462
-6% -$46.1K ﹤0.01% 1534
2018
Q1 		$576K Sell
7,119
-439
-6% -$33.8K ﹤0.01% 1710
2017
Q4 		$444K Sell
7,558
-792
-9% -$39.7K ﹤0.01% 1908
2017
Q3 		$391K Hold
8,350
– – ﹤0.01% 2021
2017
Q2 		$300K Buy
8,350
+977
+13% +$31.2K ﹤0.01% 2164
2017
Q1 		$227K Sell
7,373
-17,203
-70% -$536K ﹤0.01% 2210
2016
Q4 		$823K Sell
24,576
-19,386
-44% -$556K ﹤0.01% 1446
2016
Q3 		$1.17K Buy
43,962
+13,451
+44% +$312K ﹤0.01% 1232
2016
Q2 		$673K Hold
30,511
– – ﹤0.01% 1505
2016
Q1 		$896K Sell
30,511
-5,480
-15% -$153K ﹤0.01% 1331
2015
Q4 		$1.19M Sell
35,991
-398,811
-92% -$13M ﹤0.01% 1196
2015
Q3 		$15.7M Buy
434,802
+62,804
+17% +$2.7M 0.04% 404
2015
Q2 		$16.7M Buy
+371,998
New +$14.5M 0.04% 403
2015
Q1 		– Sell
-5,290
Closed -$269K – 2573
2014
Q4 		$269K Hold
5,290
– – ﹤0.01% 2332
2014
Q3 		$209K Hold
5,290
– – ﹤0.01% 2468
2014
Q2 		$228K Buy
+5,290
New +$202K ﹤0.01% 2502

Other funds holding ENTA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management's ENTA Position: Q4 2024 in Review

VOYA Investment Management sold out of Enanta Pharmaceuticals (ENTA) in Q4 2024, closing a stake of 20,126 shares — an estimated $209K sold.

VOYA Investment Management first reported a position in ENTA in Q2 2014 and held it in 41 quarters. The position peaked at $16.7M in Q2 2015. 107 funds tracked by Wall St. Rank hold ENTA as of Q4 2024.

  • VOYA Investment Management reported no remaining Enanta Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • VOYA Investment Management sold 20,126 Enanta Pharmaceuticals shares in Q4 2024, an estimated $209K.
  • VOYA Investment Management first reported a position in Enanta Pharmaceuticals in Q2 2014 and held it in 41 quarters.
  • VOYA Investment Management's Enanta Pharmaceuticals position peaked at $16.7M in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2024.

Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.